Cross-sectional study of adherence to venous thromboembolism prophylaxis guidelines in hospitalized patients. The Trombo-Brit study by Federico Jorge Bottaro et al.
Bottaro et al. Thrombosis Journal 2012, 10:7
http://www.thrombosisjournal.com/content/10/1/7ORIGINAL CLINICAL INVESTIGATION Open AccessCross-sectional study of adherence to venous
thromboembolism prophylaxis guidelines in
hospitalized patients. The Trombo-Brit study
Federico Jorge Bottaro1*, José Manuel Ceresetto2, John Emery1, Julio Bruetman1, Nicholas Emery1,
Débora Pellegrini1, Victoria Pinoni1, Gastón Piñeiro1, Laura Fox1, María Eugenia Orrico1, Silvina Palmer2,
Sebastián Prieto2 and Eduardo Bullorsky2Abstract
Background: DVT is the main cause of death in hospitalized patients and thromboprophylaxis is the only way to
prevent these deaths. International recommendations suggested that active monitoring of DVT/PE prophylaxis can
improve the efficacy in Hospitals.
Methods: We performed a cohort study in three consecutives periods to evaluate DVT prophylaxis in 388 adults
hospitalized in a General Hospital.
Results: 85% of the population had high risk factors for DVT. Thromboprophylaxis was in accordance with local
and International guidelines (ACCP 2008) in 72.7% and 86% of the patients respectively. No significant difference
could be founded between clinical and surgical patients. One every 10 patients received higher prophylaxis than
suggested by guidelines and two out of ten received deficient or no prophylaxis. The worst 2 groups of patients
were those with moderate/low risk of DVT and the group with a contraindication to pharmacologic prophylaxis.
We observed a progressive improvement of the DVT prophylaxis in the 3 periods of evaluation.
Conclusions: Although the rate of recommended thromboprophylaxis is higher than many other reports in the
region we still have some areas where we need to improve. Regular audits like these are very helpful to find out
what specific areas of the hospital needs some careful attention in order to have a better quality of assistance.Introduction
At present, venous thromboembolism (VTE) is a major
problem for international public health policies [1]. It is
the first cause of death in hospitalized patients, and the
third cause of death of cardiovascular origin. In fact, it is
the most important clinical problem in many patient
subgroups: it is the first cause for readmission after hip
arthroplasty and the first cause of death during preg-
nancy, after gall-bladder surgery and hernia repair [2].
The Federal Agency for Health Research and Quality
(AHRQ) in the U.S. (United States) considers that the
appropriate use of thromboprophylaxis (TP) is the most* Correspondence: febottaro@hotmail.com
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reproduction in any medium, provided the orimportant procedure today for an institution to improve
the quality of its practices [1].
One of the dominant characteristics of this disease is
that for every symptomatic pulmonary embolism diag-
nosed, there are 2.5 cases of VTE that we are not able to
identify. Moreover, 40 to 60% of the deaths from VTE
occurs in patients whom lacked a previous diagnosis of
deep vein thrombosis (DVT), and 20% of the patients
have a sudden death secondary to massive embolism as
their first and only symptom [3]. To put these numbers
in perspective, the total number of deaths from this con-
dition in hospitalized patients in England surpasses that
of the combined deaths from breast cancer, AIDS
(acquired immune deficiency syndrome) and traffic acci-
dents [4].
Antithrombotic prophylaxis is the only tool we have to
prevent these deaths. For this reason multiple guidelinesLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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tries for effective prevention in patients at risk [5].
Nevertheless, despite the efforts of many physicians
reflected in innumerable journals, and the seriousness
that this problem has merited in the published literature,
the truth is that not enough is done for adequate
prophylaxis. The ENDORSE study, a cross-sectional
study that evaluated the appropriateness of TP indica-
tions according international antithrombotic guidelines
done in 68,000 hospitalized patients worldwide (includ-
ing four Latin American countries), showed that only
50% of patients received adequate TP [6]. Furthermore,
36% of surgical patients and 52% of medical patients did
not receive any prophylaxis at all, despite being at risk
for VTE [6]. It also showed that 50–70% of thrombo-
embolic events occurred in medical patients [7] [8]. It is
estimated that 1 out of every 6 VTEs can be avoided
with adequate TP [9].
The formal recommendation for TP in the 8th consen-
sus of the American College of Chest Physcians, pub-
lished in CHEST (ACCP 2008), states that every
institution should have a formal strategy for active pre-
vention of VTE [1]. These strategies should include all
measures that have shown to be effective in improving
TP, including periodic monitoring and internal audits of
the effectiveness of TP [10].
The primary objective of the study was to determine
the proportion of hospitalized patients who are pre-
scribed adequate prophylaxis for VTE in accordance to
local institutional guidelines. The secondary objective
was to determine the proportion of patients at risk for
VTE during their hospital stay who received some form
of prophylaxis as recommended by the ACCP 2008
international guidelines.
Materials and methods
The Trombo-Brit study is a cross-sectional study under-
taken at the Hospital Británico in Buenos Aires. Our in-
stitution is a high-complexity acute-care general
hospital, with 250 beds in its admission area, 176 of
which are for general adult hospitalized patients. VTE is
performed on preprinted medical orders with a special
section in which the attending physician must select
options for any of the following modalities: no prophy-
laxis, graduated compression elastic stockings (ES),
intermittent pneumatic limb compression (IPC), or
pharmacological prophylaxis. In case that pharmaco-
logical prophylaxis is selected, the name of the drug
must be stated as well as its dose, route and frequency
of administration.
The institutional recommendations for VTE prophy-
laxis are based on ACCP recommendations and were
developed by a steering committee in the year 2001, and
updated before the survey was conducted [11]. They areavailable for consultation in every hospital ward. The
guidelines were developed to be used in patients over
the age of 18, admitted to the hospital’s general wards
and special care units (coronary care unit, intensive care
unit and cardiovascular surgery recovery areas). Accord-
ing to the presence and combination of diverse risk fac-
tors, the patients are stratified in four risk groups: low,
moderate, high and very high risk. For each group, a first
line strategy is recommended and other options are sug-
gested (see Additional file 1: Annex 1 for a summary
version of the guidelines).
Population included in the study
Patients that met the following inclusion criteria were
included: 1) patients over the age of 18 years old; 2) ad-
mission to general wards or to any of the special care
units; 3) more than 24 h of admission. Patients
excluded from the study were those admitted to certain
areas like Maternity or Neonatology, those who had less
than 24 h of hospitalization, and patients who were re-
ceiving anticoagulant therapy for conditions such as
atrial fibrillation, prosthetic heart valves, venous
thromboembolism, etc.
Procedures
The data was collected by physicians of the Internal
Medicine and Hematology departments, with previous
instructions on how to fill in the case report forms. Each
ward was evaluated by a different physician than the one
in charge of the ward and without previously alerting to
the attending physicians.
A case report form (CRF) for data collection was devel-
oped by the authors to estimate the adequacy of the
prophylaxis prescriptions according to the institutional
guidelines for TP. In order to obtain the TP adequacy
rate according to the ACCP 2008 recommendations, the
CRF was adapted to the one used in the ENDORSE study
[6], which was provided by its principal investigator in a
personal communication.
Demographic general data (age, sex, height, weight,
day of admission) were collected, as were the reason of
clinical admission (medical patients) and type of surgery
(surgical patients). Clinical conditions associated to a
higher risk of bleeding were recorded as were contrain-
dications to anticoagulation such as low platelet count,
kidney failure, and presence of active bleeding or of pre-
existing coagulopathy. For surgical patients, the type of
surgery and anesthesia employed, duration of surgery, its
cause and associated risk factors for VTE were assessed.
Also, information on the VTE prophylaxis used was
obtained: the drug prescribed and its dosage, date of
commencement, and the indication of mechanical mea-
sures for TP. In the cases where mechanical measures
were indicated for TP, the investigators were instructed
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patients who met the inclusion and exclusion criteria
were stratified in four risk categories for the develop-
ment of VTE: low, moderate, high and very high risk of
DVT according to the presence of different risk factors
as detailed in the local guidelines. TP prescriptions were
considered as “adequate” if the medical prescription coin-
cided with one of the options for prophylaxis listed in the
guidelines; “deficient” if patients had not received TP or
if it was less than the recommended by the guidelines
and “excessive”, when patients received more TP than
the recommended one or if TP was prescribed in situa-
tions where it was considered unnecessary. A global ad-
herence rate was obtained by dividing the number of
total adequate indications over number of total
indications.
Contraindications to pharmacological prophylaxis
were defined as at least one of the following condi-
tions: a platelet count less than 50.000/mm3, active
bleeding or suspicion thereof, recent intracranial
hemorrhage (< 7 days), known bleeding disorder or se-
vere hepatic failure.
Data of renal function, height and body weight were
collected to calculate the creatinine clearance by Cock-
croft’s method and body mass index (BMI). The serum
creatinine level closest to the date of inclusion was
recorded. To evaluate the secondary objective (adequacy
of the prescriptions to the recommendations of
the ACCP guidelines), patients at risk for VTE were
stratified in accordance to ACCP 2008 guidelines (see
Additional file 2: Annex 2, Tables 1 and 2) [1]. Medical
patients were stratified in two groups: patients at risk for
VTE and patients with no risk. Surgical patients were
grouped in four risk categories: low, moderate, high and
very high of DVT. The global adherence rate was deter-
mined by the quotient of total adequate indications over
total indications performed in all the patients at risk for
VTE.
Statistical analysis
A sample size of 264 patients was calculated based on an
estimate of 50% of adherence rate as reported in studies
that included Latin American countries [6] [12] (80% po-
tency and an alpha error of 0.05, accepted error 11%). It
was estimated that it would be necessary to enroll at least
350 patients since it was estimated that approximately
30% of them would not meet the pre-specified inclusion
criteria. To achieve the required sample size, three sur-
veys were performed separated by an interval of 25 days
each.
The data were analyzed using the statistical software
StataW 10.1 and MicrosoftW ExcelW 2007. Categorical
variables were summarized by frequency and percentage.
Quantitative variables were described using mean(standard deviation, SD) or median (interquartile range,
IQR) according to whether they had symmetrical or
asymmetrical distribution respectively. Because the study
design included the realization of the overall survey at
three different times, we foresaw the possibility of occur-
rence of a “learning effect” by which the adherence of
the indications to the guidelines would improve with
systematic monitoring [10]. For this reason we devel-
oped a logistic regression model to assess independent
factors associated with non-adherence to recommenda-
tions of institutional TP adjusted for the time of sur-
vey (periods 1, 2 and 3). The following variables were
included in the univariate analysis: age, sex, BMI over
30, cancer, type of admission (medical or surgical),
area of admission (general ward or special care units),
lower limb immobility, presence of infection, contrain-
dications to pharmacological prophylaxis, history of
chronic obstructive lung disease or respiratory failure,
and current respiratory infection. Variables that
reached a p value < 0.2 in the univariate analysis were
incorporated into the initial model in a sequential
fashion, and remained in the model if they reached a
p value < 0.05 in the Wald test, or if they produced
significative changes in the coefficient of another vari-
able already included in the model. Model calibration
was evaluated by the Homer-Lemeshow “goodness of
fit” statistical test. Analysis of area under the ROC
curve (receiver operator characteristic analysis) was
planned to determine whether the model adequately
discriminated subjects with and without the event.Ethical considerations
The study protocol was designed by the two principal
authors (FJB and JMC), and approved by the Hospital
Británico’s Institutional Review Board (IRB). Due to the
fact that the study only involved collection of non sensi-
tive data, the IRB granted the investigators an exception
to the obtaining of an informed consent from each
patient.Results
Between July and September 2010, the three planned
surveys were performed. A total of 409 patients were
analyzed, of which 78.7% (n = 322) were eligible in ac-
cordance to the study criteria (see Figure 1). Eighty
seven patients (21.3%) were excluded from analysis be-
cause of the presence of either one of the predefined ex-
clusion criteria (66 patients were on anticoagulant
therapy, three patients under 18 years old and two ob-
stetric patients that were admitted in a general ward,
four patients had expected hospital stay of less than
24 h, and twelve patients had insufficient data in their
medical record for the survey).
Total Patients analyzed
N= 401
65 patients excluded for being       
on anticoagulant treatment
3 patients excluded for being 
under the age of 18
4 patients excluded for having 
insufficient data on their 
medical record
2 patients excluded for being 
out of their corresponding area 
(obstetrics patients)
4 patients excluded for having 
an expected length of stay less 
than 24 hours
Total population that met 
inclusion and exclusion criteria 
N=322        
Figure 1 Flow chart of patients enrolled in the study.
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to the medical group (68%), and 103 (32%) to the sur-
gical group. The clinical characteristics of each group
are summarized in Table 1. The overall median age
was 63 years old (IQR 54–76) and 45% of patients
(n = 144) were women. The overall median length of
hospitalization until the survey was 5 days (IQR 2–13).
The median length of hospitalization up to the surveyTable 1 Summary of clinical characteristics of included patien
Total N=3
Female Sex, n (%) 144 (44.7
Age (years) † 63 ± 18
BMI (kg/m2) † 25.9 ± 5.3
Length of stay up survey,median (IQR) 5 (2 - 1
Renal failure (ClCreat<30), n (%) 15 (4.75
Risk for developing VTE, n (%) Low 10 (3.11
Moderate 26 (8.07
High 228 (70.8
Very high 58 (18)
BMI: body mass index, ClCreat: creatinine clearence (Cockcroft), IQR: interquartile ra
† Mean ± standard deviation.was 4 (IQR 1–9) and 6 days (IQR 3–14) for the surgi-
cal and medical groups respectively.
According to the criteria for risk stratification of our
institutional guidelines more than 85% of patients
(n = 286) belonged to the high and the very high risk
groups of developing VTE (89.3% and 88.5% for the sur-
gical and medical group respectively). Only 36 patients
(11.2%) were considered at low or moderate risk of
developing venous thrombosis.
Approximately one third of the patients (31.7%, n=102)
had cancer and 72.6% (n=234) had immobilization, defined
as confinement to bed or to a chair for at least 50% of the
day. Near 20% of surgical and 14.2% of medical patients
were obese (total 15.6%, BMI greater than 30 kg/m2)(see
Table 2). Another frequent risk factor identified was
chronic obstructive pulmonary disease (COPD) presenting
in 10.5% (n=34) of patients.
Reasons for admission in both groups are described in
Tables 3 and 4.
The overall TP adherence rate according to institu-
tional guidelines was 72.7% (95% CI 63 – 80.5%). Ad-
equate TP in the high and very high risk groups was
found in 79% of patients (227/284, 95% CI 71.6 –
87.2%), whilst in the low risk group, antithrombotic pre-
vention was found to be adequate in 50% of the patients.
In contrast, only 7.7% of the patients evaluated in the
moderate risk group had an adequate TP (Table 5). In
these two last groups (low and moderate risk) we
observed that in most cases the TP was inadequate due
to an excessive prescribed dose of low molecular weight
heparin (LMWH)(25/36 patients, 69.4%), and in only
14% of them (5/36) inadequacy was due to no TP at all.
However, as the patients at low and moderate risk for
VTE admitted to hospital represented only 11% of the
total population, the weight of this incorrect prophylaxis
did not have a significant impact on the overall adequate
TP rate.
The proportion of adequate TP in the surgical group
in accordance to local guidelines was 76.7% (95% CIts
22 Surgical N=103 (32%) Medical N=219 (68%)
) 40 (38.8) 104 (47.5)
.42 61.13 ±18.9 63.8 ±18.2
1 26.5 ±5.6 25.6 ±5.17
3) 4 (1 - 9) 6 (3 - 14)
) 1 (1.01) 14 (6.45)
) 4 (3.9) 6 (2.74)
) 7 (6.8) 19 (8.68)
1) 38 (36.9) 190 (86.76)
54 (52.4) 4 (1.83)
nge, VTE: venous thromboembolism.
Table 2 Preexisting risk factors for developing VTE {
Total N=322 n (%) Medical N=219 n (%) Surgical n=103 n (%)
History of VTE 1 (0.31) 1 (0,46) 0
Heart failure 10 (3.11) 9 (4,11) 1 (0,97)
COPD 34 (10.56) 28 (12,8) 6 (5,83)
Lower limb venous insufficiency 14 (4.35) 8 (3,65) 6 (5,83)
BMI > 30 kg/m2 50 (15.6) 31 (14,22) 19 (18,45)
Cancer † 102 (31.7) 61 (27,8) 41 (39,8)
Lower limb immobility } 67 (20.8) 57 (26) 10 (9,7)
Complete rest for over 72 hs ¥ 167 (51.8) 124 (56.6) 43 (41.7)
VTE: venous thomboembolism, COPD: chronic obstructive pulmonary disease, BMI: body mass index.
† Active cancer, cancer surgery or cancer treatment at present.
} Immobility prior to admission due to lower limb paresis or paralysis.
¥ Reduced mobility (rest in bed or a chair for over 50% of the time, and not moving further than the toilet).
{ The frequency of risk factors surpasses the total number of patients, as some subjects had more than one risk factor. No patient with inherited prothrombotic
states were found in the analyzed group. One patient in the anticoagulated group had a history of a prothrombotic condition.
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intervention (n = 39, 38% of the patients in the surgical
group) had an 84.6% adequate TP rate (33/39). This
group of surgical patients had the highest adherence
level for DVT prophylaxis. Adequate TP rate in the
medical group was 70.3% (95% CI 60 – 78%).
About 20% of admitted patients belonging to high and
very high risk categories received inadequate TP (59/
286), being deficient in 88% of cases (52/59). In analyz-
ing the reason for this deficient TP we found that half
(26/52, 50%) of them were patients who had contraindi-
cations for pharmacological prophylaxis, and mechanical
measures (IPC/elastic stockings) for TP were not pre-
scribed or were not implemented.
Table 6 shows patients with a contraindication for
pharmacological prophylaxis, and those who had
received unfractionated heparin (UFH) due to severe









Orthopedic surgery other than THR, TKR and HFS




THR: total hip replacement; TKR: total knee replacement; HFS: hip fractures surgery(calculated creatinine clearance less than 30 ml/min) and
most of them belonged to the medical group (14 of 15
patients). Among the causes of contraindication for the
use of antithrombotic drugs, 9 patients (2.78%) had active
bleeding and 21 patients (6.5%) had severe
thrombocytopenia (less than 50,000 platelets/mm³).
Though the distribution of patients with contraindica-
tions for pharmacologic TP was even among the surgical
and medical groups, 88% of them (31/35) were in the
high risk category of DVT. Of all patients with contra-
indication for the use of antithrombotic drugs, only a
20% received correct TP (6/35). This makes these
patients a special interest group because of their high risk
for VTE, and the large number of errors due to the scant
use of mechanical measures.
Pharmacologic prophylaxis was the most frequent
method used for DVT prevention in near 80% of the
patients (n = 232, 78%) and its use was slightly lesswith adequate prophylaxis for VTE
Surgical (n/%) Adequate prophylaxis
8 (7.8%) 6 (75%)
5 (4.9%) 5 (100%)
10 (9.8%) 7 (70%)
4 (3.9%) 2 (50%)
11 (10.8%) 8 (72.7%)
5 (4.9%) 4 (80%)
2 (1.9%) 0
5 (4.9%) 4 (80%)
3 (2.9%) 3 (100%)
36 (34.3%) 30 (83.3%)
6 (5.9%) 4 (66.7%)
8 (7.8%) 6 (75%)
103 79 (76.7%)
.
Table 4 Causes for admission and/or clinical risk conditions for VTE in medical patients †
Medical pts. (n/%) Adequate prophylaxis
Congestive heart failure 20 (9.1%) 16 (80%)
Non-respiratory infection 66 (30.1%) 48 (72.7%)
CVA (ischemic and hemorrhagic) 15 (6.8%) 10 (66.7%)
Acute respiratory failure (COPD exacerbation, pneumonia or other etiology) 64 (29.2%) 50 (78%)
Multiple Trauma 3 (1.37%) 1 (33%)
Acute inflammatory and/or rheumatologic condition. 12 (5.5%) 9 (75%)
AMI (including acute coronary syndromes) 11 (5%) 9 (81.8%)
Non-surgical cancer 61 (27.8%) 42 (68.8%)
TOTAL n: 219 154 (70.3%)
† The sum of risk factors can surpass the total number of patients due to more than one risk factor present.
VTE: venous thromboembolism, CVA: cerebrovascular accident, COPD: chronic obstructive pulmonary disease, AMI: acute myocardial infarction.
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patients. Most patients with pharmacologic TP received
LMWH as drug of choice (Table 7). Mechanical prophy-
laxis was chosen in 7.5% of cases and was used primarily
in patients with a contraindication to receive heparin or
as a complement to pharmacological TP. The use of
mechanical devices for TP was very erratic and only 50%
of patients with a prescription for the use of this method
actually had the device fitted (12/24 patients overall, 4/8
for elastic stockings and 8/16 for IPC).
Antithrombotic prophylaxis according to the ACCP 2008
international guidelines
In evaluating the adherence TP rate according to the
ACCP 2008 International Guidelines we found that out
of 272 evaluable patients, 235 met the standards of ad-
equate prophylaxis (86.3%, 95% CI 79.4 – 89.5%). In the
medical patient’s group the adequate TP rate was 83.3%
(95% CI 79.4 – 92.1%), whilst in surgical patients (101
evaluable patients according ACCP guidelines) this rate
was 92% (95% CI 79.6 – 96.4%).
Analysis of the surveys periods
There was a statistically significant progressive increase
in the adequate TP rate among the three periods. In
period 1, 66.1% of the prescriptions were adequate, while
in periods 2 and 3 were 71.1% and 81.5% respectively





Low 5 (50) 0 (0)
Moderate 2 (7.69) 5 (19.23)
High 179 (78.5) 44 (19.3)
Very High 48 (83) 8 (13.8)
TOTAL 234 (72.67) 57 (17.7)
TP: thromboprophylaxis.
{ Inadequate due to excess, since the dose prescribed for pharmacological prophylmodel we found that the presence of contraindication
for pharmacological TP (OR 28, 95% CI 10.6 – 75) and
belong to low and moderate risk categories (OR 25.2,
95% CI 10 – 64) were independent risk factors for poor
adherence to the TP guidelines. The final model showed
adequate calibration and discrimination.
Discussion
Antithrombotic prevention was adequate in 72% of ad-
mitted patients according to the Hospital Británico’s in-
stitutional guidelines for TP. In 10% of patients
prevention was inadequate due to “excess” of thrombo-
prophylaxis (31/322), and in 18% due to “deficit” in pre-
scribing. If we use the 8th ACCP International
Consensus Guidelines as a comparator, the percentage
of patients receiving adequate prophylaxis was 86%. In a
comparable study (ENDORSE) where the same methods
were used, the adequate TP rate in hospitalized patients
in the 4 participating Latin American countries was less
than 50% [6].
A 70% of patients in the medical group received ad-
equate prophylaxis. If we add to this group the patients
whom received prophylaxis higher than recommended
(excessive TP), we would find that 90.4% of patients
received some form of prevention of VTE. Nevertheless,
one out of every five high-risk medical patients (44/194)
did not receive any TP, including patients with stroke
(66% adequate TP rate), and patients with active cancerInadequate (excess) {
N (Group %)
Total
(% of total patients)
5 (50) 10 (3.11)
19 (73.1) 26 (8.07)
5 (2.2){ 228 (70.81)
2 (3.45){ 58 (18)
31 (9.63) 322 (100)
axis was higher than that suggested, even adjusted for body mass index.
Table 6 Contraindications to pharmacological TP or heparin dosage adjustment necessity †
Total (n=322) Medical (n=219) Surgical (n=103)
Severe renal failure (ClCreat ≤ 30 ml/min) ¥ 15 (4.7%) 14 (6.45%) 1 (1.01%)
Thrombocytopenia (<50000/mm3) 21 (6.52%) 21 (9.59%) 0
CNS hemorrhage in previous 7 days 4 (1.24%) 4 (1.83%) 0
Severe liver failure 7 (2.17%) 6 (2.74%) 1 (0.97%)
Suspected or active bleeding 9 (2.8%) 9 (4.11%) 0
Known bleeding diathesis 3 (0.93%) 2 (0.91%) 1 (0.97%)
TOTAL patients with contraindications 35 (11%) 32 (14.6) 3 (2.9)
TP: thromboprophylaxis, ClCreat: creatinine clearence, CNS: central nervous system.
† Some patients had more than one risk factor for bleeding.
¥ Adjustments required and/or change of drug. Calculations made on 316 patients (n=217 medical group and n=99 in the surgical group).
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high-risk medical patients who had inadequate TP by
deficient prescription, also had contraindications for
pharmacological prophylaxis (25/38, 65.8%). In other
words, more than half of the errors of TP in high-risk
patients were due to a failure in prescription or because
of a failure in implementing mechanical measures (IPC/
ES). It is notable that of 35 patients in whom pharmaco-
logical prophylaxis was contraindicated, only 6 (17%)
had adequate TP and in 28 patients (80%) it was inad-
equate due to absence of any prophylaxis. Moreover,
even when mechanical measures were prescribed by the
attending physician, 50% of cases they were not carried
out because the device was not available.
Only 36 of the 322 patients had low or moderate risk
for VTE. This probably was due to the fact that the Hos-
pital is an acute care institution, where most patients
have multiple risk factors for VTE.
Given the above, it is not surprising that the analysis
of the logistic regression model identified both the pres-
ence of a contraindication to pharmacological TP and
belonging to the groups of low and moderate risk, as in-
dependent factors associated to poor adherence to the
local guidelines. Although the confidence interval of this
association is very wide, and this may be due to the lim-
ited number of patients with these characteristics, the
lower limit of the confidence interval for the OR
obtained in both cases is 10. This means that, in the bestTable 7 Summary of VTE prophylaxis measures used
Total n=322
A) Mechanical prophylaxis: 24 (7.5%)
Graduate-compression elastic stockings 8 (2.5%)
Pneumatic intermittent compression 16 (5%)
B) Pharmacological prophylaxis: 252 (78%)
Low molecular weight heparin 211 (84%)
Unfractionated heparin 40 (16%)
Fondaparinux 1 (0.4%)
VTE: venous thromboembolism.case, the presence of either of these two factors multi-
plies 10 times the chance for inadequate TP
prescription.
The fact that the majority of patients at the Hospital
were in the high risk category for VTE, simplifies the
prescription of antithrombotic prophylaxis, due to the
lower need for indicating different doses of antithrombo-
tic agents and the widely use in our institution of
LMWH in moderate doses.
Some patients at moderate risk for VTE should have
received a lower dose of LMWH, a fact not always taken
into account by the attending physician, increasing the
errors due to an excess of prescription. In fact, one out
of ten patients received a higher dose of heparin than
the recommended according to their risk and this could
potentially expose them to a higher incidence of
bleeding.
Study limitations
Being a cross-sectional study, as all of this type, we
could not know the incidence of VTE of the population
surveyed. In addition, as the study was performed in
three different periods, there could have been a “learning
effect” in the attending physicians. This showed up in
the statistical analysis, as there was a significant differ-
ence in the adherence rate in the 3 different periods.
Due to the limited number of patients, it was not pos-
sible to evaluate this effect in depth.Medical n=219 Surgical n=103
17 (7.7%) 7 (6.8%)
6 (2.7%) 2 (2%)
11 (5%) `5 (4.8%)
164 (75%) 88 (85%)
130 (79.%) 81 (92%)
33 (20%) 7 (7.95%)
1 (0.61%) 0
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lines for TP has not been validated prospectively to de-
termine the association between its risk category
assigned and the development of VTE, it is noteworthy
that the literature is scarce in studies of these character-
istics. In fact only a few RAMs (risk assessment meth-
ods) have been validated, and these were retrospective
validations and in special populations [13,14].
Conclusions
In conclusion we can say that while the adequate TP rate
in our hospital was higher than those reported in coun-
tries in our region, there are still some areas where there
is much to improve. We should pay special attention
into two different areas: those patients with a contraindi-
cation to use pharmacological antithrombotic agents, es-
pecially those who require mechanical measures to
prevent VTE, and patients with a low or moderate risk
of DVT. The use of systematic audits will reveal in the
future new areas in which adjustments will be required.
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